Aarti Pharmalabs Share PriceAarti Pharmalabs

₹461.95
11.65 (2.59%)
As on 30 September, 2023 | 06:11 BSE: 543748 NSE: AARTIPHARMISIN: INE0LRU01027

Aarti Pharmalabs Performance

Day Range

  • Low 454.55
  • High 466.2
461.95

52 Week Range

  • Low 234.8
  • High 476.05
461.95
  • Open Price454.6
  • Previous Close450.3
  • Volume129514

Start SIP in Aarti Pharmalabs

Start SIP

Aarti Pharmalabs Share Price

  • Over 1 Month 13.96%
  • Over 3 Month 22.74%
  • Over 6 Month 65.54%

Aarti Pharmalabs Key Statistics

P/E Ratio
PEG Ratio
Market Cap Cr 4,187
Price to Book Ratio 2.7
EPS 19
Dividend 0
Relative Strength Index 65.8
Money Flow Index 49.55
MACD Signal 17.86
Average True Range 16.81

Aarti Pharmalabs Investment Rating

  • Master Rating:
  • Aarti Pharmalabs has an operating revenue of Rs. 2,863.89 Cr. on a trailing 12-month basis. An annual revenue growth of 62% is outstanding, Pre-tax margin of 13% is healthy, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 15% and 18% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 11% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 35 which is a POOR score indicating inconsistency in earnings, a RS Rating of 79 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 40 indicates it belongs to a strong industry group of Medical-Ethical Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Aarti Pharmalabs Financials
IndicatorJun 2023Mar 2023Dec 2022Mar 2022
Oper Rev Qtr Cr 3583741,137365
Operating Expenses Qtr Cr 281297905296
Operating Profit Qtr Cr 777723268
Depreciation Qtr Cr 15144212
Interest Qtr Cr 46154
Tax Qtr Cr 1517459
Net Profit Qtr Cr 484013245
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 1,513944
Operating Expenses Annual Cr 1,203761
Operating Profit Annual in Cr 308180
Depreciation Cr 5637
Interest Annual Cr 2011
Tax Annual Cr 6227
Net Profit Annual Cr 172107
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 229-65
Cash from Investing Activity Annual Cr -116-134
Cash from Financing Annual Activity Cr -157255
Net Cash Flow Annual Cr -4356
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 1,4391,284
Fixed Assets Annual Cr 950888
Total Non Current Assets Annual Cr 1,004937
Total Current Assets Annual Cr 959890
Total Assets Annual Cr 1,9631,827
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 159282
ROE Annual % 128
ROCE Annual % 1711
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2019
IndicatorJun 2023Mar 2023Dec 2022Mar 2022
Oper Rev Qtr Cr 4584851,460460
Operating Expenses Qtr Cr 3734051,198385
Operating Profit Qtr Cr 858026276
Depreciation Qtr Cr 17164714
Interest Qtr Cr 46155
Tax Qtr Cr 17165111
Net Profit Qtr Cr 474315149
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 1,9481,202
Operating Expenses Annual Cr 1,603993
Operating Profit Annual in Cr 342207
Depreciation Cr 6342
Interest Annual Cr 2112
Tax Annual Cr 6733
Net Profit Annual Cr 193122
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 263-44
Cash from Investing Activity Annual Cr -158-139
Cash from Financing Annual Activity Cr -163260
Net Cash Flow Annual Cr -5878
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 1,5581,386
Fixed Assets Annual Cr 1,026968
Total Non Current Assets Annual Cr 1,0751,012
Total Current Assets Annual Cr 1,1561,028
Total Assets Annual Cr 2,2312,040
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 172304
ROE Annual % 129
ROCE Annual % 1711
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1817

Aarti Pharmalabs Technicals

EMA & SMA

Current Price
₹461.95
11.65 (2.59%)
  • Bullish Moving Average
  • ___
  • 14
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹435.17
  • 50 Day
  • ₹407.02
  • 100 Day
  • ₹380.01
  • 200 Day
  • 20 Day
  • ₹439.74
  • 50 Day
  • ₹391.13
  • 100 Day
  • ₹380.22
  • 200 Day

Aarti Pharmalabs Resistance and Support

PIVOT
₹460.9
Resistance
First Resistance ₹467.25
Second Resistance ₹472.55
Third Resistance ₹478.9
RSI 65.8
MFI 49.55
MACD Single Line 17.86
MACD 16.34
Support
First Resistance ₹455.6
Second Resistance ₹449.25
Third Resistance ₹443.95

Aarti Pharmalabs Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 139,538 8,405,769 60.24
Week 124,585 6,788,615 54.49
1 Month 341,180 18,297,468 53.63
6 Month 305,205 17,155,579 56.21

Aarti Pharmalabs Result Highlights

Aarti Pharmalabs Synopsis

NSE-Medical-Ethical Drugs

Aarti Pharmalabs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1511.25 Cr. and Equity Capital is Rs. 45.31 Cr. for the Year ended 31/03/2023. Aarti Pharmalabs Ltd. is a Public Limited Listed company incorporated on 22/11/2019 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24100GJ2019PLC110964 and registration number is 110964.
Market Cap 4,186
Sales 1,869
Shares in Float 4.89
No of funds 136
Yield
Book Value 2.91
U/D Vol ratio 2.3
LTDebt / Equity
Alpha 0.18
Beta 0.4

Aarti Pharmalabs

Owner NameJun-23Mar-23Jan-23
Promoters 45.98%45.98%44.16%
Mutual Funds 2.72%5.11%6.7%
Insurance Companies 7.06%7.73%8.01%
Foreign Portfolio Investors 7.43%7.69%11.89%
Financial Institutions/ Banks 0.02%0.02%0.02%
Individual Investors 30.23%28.35%24.66%
Others 6.56%5.12%4.56%

Aarti Pharmalabs Management

Name Designation
Mr. Chandrakant Vallabhaji Gogri Chairman Emeritus
Mr. Rashesh C Gogri Chairman & Non-Exe.Director
Mrs. Hetal Gogri Gala Vice Chairperson & M.D
Mr. Narendra J Salvi Managing Director
Mr. Rajendra V Gogri Non Executive Director
Mr. Parimal H Desai Non Executive Director
Mr. Bhavesh R Vora Independent Director
Mrs. Jeenal K Savla Independent Director
Mrs. Rupal A Vora Independent Director
Mr. Vilas Gajanan Gaikar Independent Director
Mr. Vinay G Nayak Independent Director

Aarti Pharmalabs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Aarti Pharmalabs Corporate Action

Date Purpose Remarks
2023-08-05 Quarterly Results
2023-05-12 Audited Results

Aarti Pharmalabs MF Shareholding

Name Amount(cr)
Aditya Birla Sun Life Flexi Cap Fund Growth 17296
Axis Small Cap Fund Regular Growth 15847
HDFC Large and Mid Cap Fund Growth 11198
UTI Mid Cap Fund Regular Plan Growth 8881
HDFC Multi Cap Fund Regular Growth 8263
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

Aarti Pharmalabs FAQs

What is Share Price of Aarti Pharmalabs ?

Aarti Pharmalabs share price is ₹461 As on 30 September, 2023 | 05:58

What is the Market Cap of Aarti Pharmalabs ?

The Market Cap of Aarti Pharmalabs is ₹4186.5 Cr As on 30 September, 2023 | 05:58

What is the P/E ratio of Aarti Pharmalabs ?

The P/E ratio of Aarti Pharmalabs is As on 30 September, 2023 | 05:58

What is the PB ratio of Aarti Pharmalabs ?

The PB ratio of Aarti Pharmalabs is 2.7 As on 30 September, 2023 | 05:58

Q2FY23